Direxion mRNA ETF

Доходность за полгода: 0%
Отрасль: Health & Biotech Equities

BeiGene, Ltd.
Vertex
Alnylam Pharmaceuticals, Inc.
BioNTech SE
Moderna
Arcturus Therapeutics Holdings Inc.
PTC Therapeutics, Inc.
Intellia Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Maravai LifeSciences Holdings, Inc.
Ionis Pharmaceuticals
Sangamo Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc.
Остальные
BeiGene, Ltd.: 6.7%Vertex: 6.6%Alnylam Pharmaceuticals, Inc.: 6.3%BioNTech SE: 6.1%Moderna: 6%Arcturus Therapeutics Holdings Inc.: 5%PTC Therapeutics, Inc.: 4.9%Intellia Therapeutics, Inc.: 4.8%Sarepta Therapeutics, Inc.: 4.7%Maravai LifeSciences Holdings, Inc.: 4.6%Ionis Pharmaceuticals: 4.1%Sangamo Therapeutics, Inc.: 4%Arrowhead Pharmaceuticals, Inc.: 3.7%Остальные: 32.8%Доля акций по компаниямporti.ru
Сохранить SVG
Сохранить PNG
Сохранить CSV
НазваниеОтрасльДоля, %P/BVP/SP/EEV/EbitdaДивидендная доходность
BeiGene, Ltd. BeiGene, Ltd. Healthcare 6.65 5.42 7.8 0 -15.07 0
Vertex Vertex Healthcare 6.6 6.28 9.35 29.17 205.99 0
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Healthcare 6.32 452.37 13.5 0 -168.98 0
BioNTech SE BioNTech SE Healthcare 6.14 1.36 9.62 24.73 -46.17 0
Moderna Moderna Healthcare 5.95 1.39 4.67 8.96 -4.1 0
Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings Inc. Healthcare 4.96 3.03 5.35 49.99 -441.27 0
PTC Therapeutics, Inc. PTC Therapeutics, Inc. Healthcare 4.89 -3.2 4.36 0 -25.96 0
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. Healthcare 4.77 2.65 76.74 0 -5.28 0
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Healthcare 4.65 10.17 6.87 55.57 -36.23 0
Maravai LifeSciences Holdings, Inc. Maravai LifeSciences Holdings, Inc. Healthcare 4.55 1.11 3.03 7.19 20.45 0
Ionis Pharmaceuticals Ionis Pharmaceuticals Healthcare 4.07 8.87 7.4 122.59 -13.44 0
Sangamo Therapeutics, Inc. Sangamo Therapeutics, Inc. Healthcare 3.98 20.73 8.17 0 -4.39 0
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. Healthcare 3.66 12.14 653.4 478.56 -4.86 0
67.1940.1862.3359.75-41.490

Оплатите подписку

Больше функциональности и данных для анализа компаний и портфеля доступно по подписке